These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25196016)
1. Enhanced autophagy by everolimus contributes to the antirestenotic mechanisms in vascular smooth muscle cells. Tang B; Dong X; Wei Z; Qiao H; Jiang H; Liu B; Sun X J Vasc Res; 2014; 51(4):259-68. PubMed ID: 25196016 [TBL] [Abstract][Full Text] [Related]
2. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration. Lavigne MC; Grimsby JL; Eppihimer MJ J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747 [TBL] [Abstract][Full Text] [Related]
3. Everolimus sensitizes Ras-transformed cells to radiation in vitro through the autophagy pathway. Su YC; Yu CC; Hsu FT; Fu SL; Hwang JJ; Hung LC; Lee MS; Chiou WY; Lin HY; Hung SK Int J Mol Med; 2014 Nov; 34(5):1417-22. PubMed ID: 25200811 [TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 Inhibited Diabetes-Induced Phenotypic Switching of Vascular Smooth Muscle Cells Through Activating Autophagy. An XR; Li X; Wei W; Li XX; Xu M Cell Physiol Biochem; 2018; 50(2):745-756. PubMed ID: 30308483 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Braun-Dullaeus RC; Mann MJ; Seay U; Zhang L; von Der Leyen HE; Morris RE; Dzau VJ Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1152-8. PubMed ID: 11451744 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade. Chen S; Dong S; Li Z; Guo X; Zhang N; Yu B; Sun Y Cell Physiol Biochem; 2017; 44(1):215-228. PubMed ID: 29131001 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling. Osman I; Segar L Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070 [TBL] [Abstract][Full Text] [Related]
9. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Kluk MJ; Hla T Circ Res; 2001 Sep; 89(6):496-502. PubMed ID: 11557736 [TBL] [Abstract][Full Text] [Related]
10. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway. Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894 [TBL] [Abstract][Full Text] [Related]
11. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression. Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661 [TBL] [Abstract][Full Text] [Related]
12. Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury. Nakagawa S; Nishihara K; Inui K; Masuda S Eur J Pharmacol; 2012 Dec; 696(1-3):143-54. PubMed ID: 23022334 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin Inhibits the Apoptosis of Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells by Inhibiting p38 via Autophagy. Jo JH; Park HS; Lee DH; Han JH; Heo KS; Myung CS J Pharmacol Exp Ther; 2021 Jul; 378(1):10-19. PubMed ID: 33846234 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535 [TBL] [Abstract][Full Text] [Related]
16. Everolimus (RAD001) inhibits the proliferation of rat vascular smooth muscle cells by up-regulating the activity of the p27/kip1 gene promoter. Ran B; Li M; Li Y; Lin Y; Liu W; Luo Q; Fu Y; Tang Q; Yang Y; Pu Y Anatol J Cardiol; 2016 Jun; 16(6):385-91. PubMed ID: 27163533 [TBL] [Abstract][Full Text] [Related]
17. Everolimus induces G Chen G; Ding XF; Bouamar H; Pressley K; Sun LZ Am J Physiol Cell Physiol; 2019 Aug; 317(2):C244-C252. PubMed ID: 31116586 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferation of cardamonin is involved in mTOR on aortic smooth muscle cells in high fructose-induced insulin resistance rats. Liao Q; Shi DH; Zheng W; Xu XJ; Yu YH Eur J Pharmacol; 2010 Sep; 641(2-3):179-86. PubMed ID: 20566415 [TBL] [Abstract][Full Text] [Related]
19. Dahuang zhechong pill containing serum inhibited platelet-derived growth factor-stimulated vascular smooth muscle cells proliferation by inducing G1 arrest partly via suppressing protein kinase C α-extracellular regulated kinase 1/2 signaling pathway. Liu N; Liu JT; Ji YY; Lu PP Chin J Integr Med; 2012 May; 18(5):371-7. PubMed ID: 21533776 [TBL] [Abstract][Full Text] [Related]
20. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Yamakawa T; Tanaka S; Numaguchi K; Yamakawa Y; Motley ED; Ichihara S; Inagami T Hypertension; 2000 Jan; 35(1 Pt 2):313-8. PubMed ID: 10642317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]